CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 125,000 shares at $13.12 ($1,640,313)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Former 10% Owner bought 312,500 shares at $16.00 ($5,000,000)
- 4/A Conversion Director acquired 4,409,991 shares (conversion)
- 4 Conversion 10% owner acquired 4,409,991 shares (conversion)
- 4 Conversion Chief Operating Officer acquired 8,501 shares (conversion)
- 4 Open-market buy Director bought 156,250 shares at $16.00 ($2,500,000)
- 4 Open-market buy 10% owner bought 156,250 shares at $16.00 ($2,500,000)
- 4 Conversion Chief Financial Officer acquired 21,254 shares (conversion)
- 4 Conversion Chief Executive Officer acquired 34,007 shares (conversion)
- 4 Conversion Director acquired 61,444 shares (conversion)
Page 9 of 11 · 203 filings